Skip to main content

Table 2 Changes in baseline BP measurements for responders at the end of 4 weeks of therapy

From: Antihypertensive efficacy of metoprolol XL/Low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in Indian patients with mild-to-moderate essential hypertension

Efficacy Parameters Metoprolol XL + Chlorthalidone (n = 32) Metoprolol XL + HCTZ (n = 32) P value
Mean SBP (mmHg) (At baseline) 153.34 ± 8.61 (138.0-170.0) 154.47 ± 11.94 (134.0-190.0) 0.667
Mean SBP (mmHg) (At 4 weeks) 126.31 ± 8.17 (110.0-138.0) 128.16 ± 5.83 (112.0-138.0) 0.303
Mean DBP (mmHg) (At baseline) 96.25 ± 5.72 (80.0-108.0) 96.18 ± 5.17 (90.0-104.0) 0.964
Mean DBP(mmHg) (At 4 weeks) 81.72 ± 6.24 (60.0-88.0) 81.53 ± 4.51 (70.0-88.0) 0.891
Mean Fall in SBP (mmHg) -27.03 ± 8.31 -26.31 ± 12.56 0.788
Mean Fall in DBP (mmHg) -14.53 ± 6.73 -14.66 ± 6.31 0.939